ARK Genomic Revolution ETF (BATS:ARKG) saw a surge in options trading activity on Friday, with investors purchasing 15,452 put options on the company. This marked a 50% increase compared to the average volume of 10,321 put options.
Several large investors have recently made changes to their positions in ARK Genomic Revolution ETF. BNP Paribas Financial Markets, Goldman Sachs Group Inc., SG Americas Securities LLC, Clearwater Capital Advisors LLC, and Cetera Investment Advisers all increased their stakes in the stock during the first and fourth quarters.
On Friday, ARK Genomic Revolution ETF stock opened at $25.34, showing a 2.1% increase. The business’s fifty-day moving average is $24.98, while its two-hundred day moving average is $27.56.
ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that focuses on companies in the genomics industry. Launched in October 2014 and managed by ARK, the fund mostly invests in stocks based on this specific theme. Investors interested in receiving daily news and ratings for ARK Genomic Revolution ETF can subscribe to MarketBeat.com’s free email newsletter.